Credo Technology Stock Analysis: Earnings Beat Followed by 20% Drop
Credo Technology recently experienced a significant drop in its stock price, falling 20% in a single trading session despite reporting an earnings beat. This unexpected decline has sparked discussions among investors about whether the sell-off presents a buying opportunity or signals deeper issues within the company. At a current price of $164.52, the stock has become a focal point for analysts, many of whom maintain a bullish outlook, with 18 of 19 recommending it as a Buy or Strong Buy.
The company, which specializes in high-speed connectivity solutions for AI data centers, reported a remarkable 114.73% year-over-year revenue increase for Q1 FY2027, totaling $479 million. Non-GAAP earnings per share reached $1.20, marking the eighth consecutive quarter of earnings beats. Despite these strong fundamentals, the stock's sharp decline raises questions about market sentiment and investor expectations.
Management has guided for Q2 revenue between $525 million and $535 million, projecting full-year growth of over 85% year-over-year, with a non-GAAP net margin around 50%. The optical segment alone is expected to exceed $600 million in revenue. However, the stock's valuation has compressed significantly, with a forward price-to-earnings ratio now near 41, down from a trailing multiple of 90.
Investor concerns are heightened by the company's customer concentration, with the top four customers accounting for a substantial portion of revenue. The largest customer represents 33% of total revenue, which poses risks if there are any capital expenditure reductions from these key clients.
The recent acquisition of Dust Photonics has added complexity to Credo's financials, with goodwill increasing dramatically and gross margins showing slight declines. The stock's price-to-sales ratio of 32 suggests limited room for error, particularly in light of a beta of 3.233, indicating high volatility.
Looking ahead, analysts are watching for key developments, including the anticipated revenue from optical products and the performance of new offerings like OmniConnect. The upcoming quarters will be critical in determining whether the current stock price represents a buying opportunity or if the market's concerns are justified.
Despite the recent drop, Credo's stock has performed well year-to-date, outpacing the broader market. The path to recovery appears contingent on several catalysts, including continued revenue growth and successful product launches. Investors are advised to monitor the company's quarterly disclosures closely, particularly regarding customer concentration and inventory levels, as these factors will significantly impact future performance.
